Management of Chronic Kidney Disease Mineral-Bone Disorder

Stephen Z. Fadem, Sharon Moe

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Chronic kidney disease mineral-bone disorder (CKD-MBD) is a systemic disorder of abnormal serum levels of mineral-related biochemistries, abnormal bone, and extraskeletal calcification. Although we have gained understanding on how these components are interrelated, our therapeutic tools remain focused on only one aspect of CKD-MBD at a time. However, the management of these disorders is also interrelated; treatments may help one aspect of the disorder but cause or accelerate another. As such, management remains a major challenge to nephrologists and requires balancing risk and benefit of the various available therapies. Our challenge for the decade ahead is to determine which combinations of therapy can be used safely together to prevent morbidity and mortality in CKD. Furthermore, the pathophysiology that sets these events into motion begins well before the onset of ESRD. Future therapies and guidelines should, therefore, also emphasize the need for earlier detection and management of CKD, shaped by the results of valid clinical trials.

Original languageEnglish
Pages (from-to)44-53
Number of pages10
JournalAdvances in Chronic Kidney Disease
Volume14
Issue number1
DOIs
StatePublished - Jan 2007

Fingerprint

Chronic Kidney Disease-Mineral and Bone Disorder
Therapeutics
Biochemistry
Chronic Kidney Failure
Minerals
Clinical Trials
Guidelines
Morbidity
Bone and Bones
Mortality
Serum

Keywords

  • calcium
  • Kidney diseases
  • phosphorus
  • renal osteodystrophy
  • secondary hyperparathyroidism

ASJC Scopus subject areas

  • Nephrology

Cite this

Management of Chronic Kidney Disease Mineral-Bone Disorder. / Fadem, Stephen Z.; Moe, Sharon.

In: Advances in Chronic Kidney Disease, Vol. 14, No. 1, 01.2007, p. 44-53.

Research output: Contribution to journalArticle

@article{1d365162f67b4e62a380b6810216f07b,
title = "Management of Chronic Kidney Disease Mineral-Bone Disorder",
abstract = "Chronic kidney disease mineral-bone disorder (CKD-MBD) is a systemic disorder of abnormal serum levels of mineral-related biochemistries, abnormal bone, and extraskeletal calcification. Although we have gained understanding on how these components are interrelated, our therapeutic tools remain focused on only one aspect of CKD-MBD at a time. However, the management of these disorders is also interrelated; treatments may help one aspect of the disorder but cause or accelerate another. As such, management remains a major challenge to nephrologists and requires balancing risk and benefit of the various available therapies. Our challenge for the decade ahead is to determine which combinations of therapy can be used safely together to prevent morbidity and mortality in CKD. Furthermore, the pathophysiology that sets these events into motion begins well before the onset of ESRD. Future therapies and guidelines should, therefore, also emphasize the need for earlier detection and management of CKD, shaped by the results of valid clinical trials.",
keywords = "calcium, Kidney diseases, phosphorus, renal osteodystrophy, secondary hyperparathyroidism",
author = "Fadem, {Stephen Z.} and Sharon Moe",
year = "2007",
month = "1",
doi = "10.1053/j.ackd.2006.10.004",
language = "English",
volume = "14",
pages = "44--53",
journal = "Advances in Chronic Kidney Disease",
issn = "1548-5595",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Management of Chronic Kidney Disease Mineral-Bone Disorder

AU - Fadem, Stephen Z.

AU - Moe, Sharon

PY - 2007/1

Y1 - 2007/1

N2 - Chronic kidney disease mineral-bone disorder (CKD-MBD) is a systemic disorder of abnormal serum levels of mineral-related biochemistries, abnormal bone, and extraskeletal calcification. Although we have gained understanding on how these components are interrelated, our therapeutic tools remain focused on only one aspect of CKD-MBD at a time. However, the management of these disorders is also interrelated; treatments may help one aspect of the disorder but cause or accelerate another. As such, management remains a major challenge to nephrologists and requires balancing risk and benefit of the various available therapies. Our challenge for the decade ahead is to determine which combinations of therapy can be used safely together to prevent morbidity and mortality in CKD. Furthermore, the pathophysiology that sets these events into motion begins well before the onset of ESRD. Future therapies and guidelines should, therefore, also emphasize the need for earlier detection and management of CKD, shaped by the results of valid clinical trials.

AB - Chronic kidney disease mineral-bone disorder (CKD-MBD) is a systemic disorder of abnormal serum levels of mineral-related biochemistries, abnormal bone, and extraskeletal calcification. Although we have gained understanding on how these components are interrelated, our therapeutic tools remain focused on only one aspect of CKD-MBD at a time. However, the management of these disorders is also interrelated; treatments may help one aspect of the disorder but cause or accelerate another. As such, management remains a major challenge to nephrologists and requires balancing risk and benefit of the various available therapies. Our challenge for the decade ahead is to determine which combinations of therapy can be used safely together to prevent morbidity and mortality in CKD. Furthermore, the pathophysiology that sets these events into motion begins well before the onset of ESRD. Future therapies and guidelines should, therefore, also emphasize the need for earlier detection and management of CKD, shaped by the results of valid clinical trials.

KW - calcium

KW - Kidney diseases

KW - phosphorus

KW - renal osteodystrophy

KW - secondary hyperparathyroidism

UR - http://www.scopus.com/inward/record.url?scp=33845904914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845904914&partnerID=8YFLogxK

U2 - 10.1053/j.ackd.2006.10.004

DO - 10.1053/j.ackd.2006.10.004

M3 - Article

C2 - 17200043

AN - SCOPUS:33845904914

VL - 14

SP - 44

EP - 53

JO - Advances in Chronic Kidney Disease

JF - Advances in Chronic Kidney Disease

SN - 1548-5595

IS - 1

ER -